EA201991971A1 - Применение фенилкреатина для профилактики или лечения экстрасистолии - Google Patents

Применение фенилкреатина для профилактики или лечения экстрасистолии

Info

Publication number
EA201991971A1
EA201991971A1 EA201991971A EA201991971A EA201991971A1 EA 201991971 A1 EA201991971 A1 EA 201991971A1 EA 201991971 A EA201991971 A EA 201991971A EA 201991971 A EA201991971 A EA 201991971A EA 201991971 A1 EA201991971 A1 EA 201991971A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
phenylcreatin
extrasystoles
application
Prior art date
Application number
EA201991971A
Other languages
English (en)
Other versions
EA037869B1 (ru
Inventor
Илья Владимирович ДУХОВЛИНОВ
Original Assignee
Алексеев, Алексей Викторович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алексеев, Алексей Викторович filed Critical Алексеев, Алексей Викторович
Priority to EA201991971A priority Critical patent/EA037869B1/ru
Publication of EA201991971A1 publication Critical patent/EA201991971A1/ru
Publication of EA037869B1 publication Critical patent/EA037869B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к области фармацевтической химии. В частности, изобретение относится к применению производного креатина - фенилкреатина для профилактики или лечения экстрасистолии.
EA201991971A 2017-01-20 2017-01-20 Применение фенилкреатина для профилактики или лечения экстрасистолии EA037869B1 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201991971A EA037869B1 (ru) 2017-01-20 2017-01-20 Применение фенилкреатина для профилактики или лечения экстрасистолии

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201991971A EA037869B1 (ru) 2017-01-20 2017-01-20 Применение фенилкреатина для профилактики или лечения экстрасистолии

Publications (2)

Publication Number Publication Date
EA201991971A1 true EA201991971A1 (ru) 2020-01-13
EA037869B1 EA037869B1 (ru) 2021-05-28

Family

ID=69374517

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991971A EA037869B1 (ru) 2017-01-20 2017-01-20 Применение фенилкреатина для профилактики или лечения экстрасистолии

Country Status (1)

Country Link
EA (1) EA037869B1 (ru)

Also Published As

Publication number Publication date
EA037869B1 (ru) 2021-05-28

Similar Documents

Publication Publication Date Title
MX2020013881A (es) Compuestos inhibidores de bcl-xl y conjugados de anticuerpo-farmaco que los incluyen.
PH12018500899A1 (en) Compositions and methods for inhibiting arginase activity
EA201891200A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890204A1 (ru) Антибактериальные соединения
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
GB2541571A (en) Pharmaceutical compositions
PH12019501097A1 (en) Magl inhibitors
MX2017011997A (es) Carbamatos de piperacina y metodos de preparacion y uso.
PH12019501102A1 (en) Magl inhibitors
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
EA201790575A1 (ru) Триазолопиразиноны в качестве ингибиторов pde1
MX2017012009A (es) Derivado de un anillo condensado y metodo de preparacion, compuesto intermedio, composicion farmaceutica y uso del mismo.
EA201792157A1 (ru) Имидазопиразиноны в качестве ингибиторов pde1
BR112017000730A2 (pt) derivados de pirrolidinona como inibidores de metap-2
EA201890449A1 (ru) Фумагиллиновые гетероциклические соединения и способы их получения и применения
MX2017011655A (es) Compuestos de aza-piridona y usos de estos.
EA201790156A1 (ru) Азетидинилоксифенилпирролидиновые соединения
MX2019001634A (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos.
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
PH12017501955A1 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer`s disease
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
EA201890911A1 (ru) Комбинация тразодона и габапентина для лечения боли
EA201991971A1 (ru) Применение фенилкреатина для профилактики или лечения экстрасистолии
EA201790020A1 (ru) Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний